Nephrology

Doç. Dr. Serhat Karadağ

Doctor and researcher İstanbul Haseki Eğitim ve Araştırma Hastanesi İstanbul
Kidney Failure, ChronicCOVID-19AlbuminuriaDiabetes Mellitus, Type 2GlomerulonephritisAnemiaInsulin ResistanceDiabetic NephropathiesCardiovascular DiseasesTuberculosis
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Kidney Failure, Chronic 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • COVID-19 5 publications
  • Albuminuria 3 publications
  • Diabetes Mellitus, Type 2 3 publications
  • Glomerulonephritis 2 publications
  • Anemia 2 publications
  • Insulin Resistance 2 publications
  • Diabetic Nephropathies 2 publications
  • Cardiovascular Diseases 2 publications
  • Tuberculosis 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNephrologysaglik.gov.trFrom source
  • Institutionİstanbul Haseki Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workKidney Failure, ChronicExtracted from 5 publications · Model version —From source
  • Publications104 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0001-9535-5063ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://hasekieah.saglik.gov.tr/TR-671864/doktorlar.html#serhat-karadagsaglik.gov.tr

Scientific work

Publications on Kidney Failure, Chronic

104 publications

  1. Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15051850 PMID 41827265 Open-access full textSource: ORCID

  2. Therapeutic Plasma Exchange Using Membrane Plasma Separation Across a Broad Spectrum of Indications: An Eight-Year Single-Center Retrospective Cohort Study

    International Journal of General Medicine, 2026

    DOI 10.2147/ijgm.s625354 PMID 42670524 Open-access full textSource: ORCID

  3. Diagnostic Performance of Plasma Levels of sST2 (Soluble Suppression of Tumorigenicity 2) in the Evaluation of Hypervolemia in Hemodialysis Patients: A Comparative Analysis With Traditional and Alternative Biomarkers

    Hemodialysis International, 2026

    DOI 10.1111/hdi.70092 PMID 42173668 Source: OpenAlex

  4. Determinants of anemia in patients with primary glomerulonephritis: a biopsy-based analysis

    Acta Clinica Belgica, 2026

    DOI 10.1080/17843286.2025.2605691 PMID 41442509 1 citation (Europe PMC) Source: ORCID

  5. The Relationship of Bioimpedance and Biochemical Data with the Blood Pressure Response to Exercise

    İç Hastalıkları Dergisi, 2025

    DOI 10.5578/ichastaliklari.2025014 Open-access full textSource: OpenAlex

  6. Extrapulmonary features of sarcoidosis

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa1895 Source: OpenAlex

  7. Age-related differences in clinical presentation, histopathology, and outcomes in minimal change disease: a TSN-GOLD national registry analysis

    Research Square, 2025

    DOI 10.21203/rs.3.rs-8070995/v1 Open-access full textSource: OpenAlex

  8. Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group

    Renal Failure, 2024

    DOI 10.1080/0886022x.2024.2341787 PMID 38637275 2 citations (Europe PMC) Open-access full textSource: ORCID

  9. Post-COVID-19 Outcomes of Patients with Primary Glomerular Diseases: A Nationwide Controlled Study

    Turkish Journal of Nephrology, 2024

    DOI 10.5152/turkjnephrol.2024.22480 Open-access full textSource: OpenAlex

  10. The role of calcitonin gene‐related peptide and substance P in the pathogenesis of dialysis headache

    Hemodialysis International, 2024

    DOI 10.1111/hdi.13120 PMID 37852938 2 citations (Europe PMC) Source: ORCID

View all 104 publications